title: Non-immune factors in chronic rejection. Is there a role for hypolipemic drugs?
authors.affiliation: Transplantation Institute, Warsaw Medical School, Poland.
authors.forename: L
authors.initials: L
authors.lastname: Paczek
authors.forename: M
authors.initials: M
authors.lastname: Bill
authors.forename: J
authors.initials: J
authors.lastname: Wyzgał
authors.forename: L
authors.initials: L
authors.lastname: Gradowska
authors.forename: Z
authors.initials: Z
authors.lastname: Gałazka
authors.forename: Z
authors.initials: Z
authors.lastname: Gaciong
mesh_terms: D000328:Adult; D001055:Apolipoproteins B / Q000097:blood; D002318:Cardiovascular Diseases / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology*; D008074:Lipoproteins / Q000097:blood; D008148:Lovastatin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D001055:Apolipoproteins B; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D002784:Cholesterol; D008148:Lovastatin